Liver transplantation due to iatrogenic injuries: two case reports.
The transjugular intrahepatic portosystemic shunt (TIPS) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. In the literature few reports have described complications after TIPS placement. Initial surgery and local hemostasis have been needed to manage abdominal bleeding: if this treatment is insufficient, it may be necessary to perform a liver transplantation. This report describes the role of liver transplantation to manage dangerous complications in 2 patients after TIPS placement, when surgical procedures and hemostasis were unable to stop the bleeding.
Di Benedetto
F
F
Liver and Multivisceral Transplant Center, University of Modena and Reggio Emilia, Modena, Italy. f.diben@virgilio.it
Mimmo
A
A
D'Amico
G
G
De Ruvo
N
N
Cautero
N
N
Montalti
R
R
Guerrini
G P
GP
Ballarin
R
R
Spaggiari
M
M
Tarantino
G
G
Serra
V
V
Pecchi
A
A
De Santis
M
M
Gerunda
G E
GE
D000328:Adult; D000437:Alcoholism / Q000150:complications; D019072:Antibiotic Prophylaxis; D005260:Female; D006503:Hepatic Veins / Q000601:surgery; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000209:etiology; D006975:Hypertension, Portal / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical / Q000379:methods; D020123:Sirolimus / Q000627:therapeutic use; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D020123:Sirolimus